Dora Nomikos
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 7
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Treatments and Studies 2
- Cancer Immunotherapy and Biomarkers 2
- Cancer Treatment and Pharmacology 2
-
- Lung Cancer Treatments and Mutations 2
- Advanced Breast Cancer Therapies 2
- Co-authors
- Dongsheng Tu (1 shared paper)Stefan Baral (1 shared paper)John R. Goffin (1 shared paper)Lesley Seymour (1 shared paper)Karen A. Gelmon (4 shared papers)Wendy R. Parulekar (4 shared papers)Yasir M. Nagarwala (2 shared papers)Kathleen I. Pritchard (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Clinical Cancer Research (1 paper)Breast Cancer Research and Treatment (1 paper)Current Oncology (1 paper)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Dora Nomikos
9 papers receiving 182 citations
Peers
Comparison fields: 5 of 43
- Oncology 102
- Cancer Research 33
- Statistics and Probability 19
- Radiology, Nuclear Medicine and Imaging 47
- Pulmonary and Respiratory Medicine 37
Countries citing papers authored by Dora Nomikos
This map shows the geographic impact of Dora Nomikos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Nomikos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Nomikos more than expected).
Fields of papers citing papers by Dora Nomikos
This network shows the impact of papers produced by Dora Nomikos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Nomikos. The network helps show where Dora Nomikos may publish in the future.
Co-authors
The 25 scholars most cited alongside Dora Nomikos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 70 | |
| 2 | 2012 | 49 | |
| 3 | 2012 | 25 | |
| 4 | 2017 | 11 | |
| 5 | 2018 | 10 | |
| 6 | 2021 | 9 | |
| 7 | 2018 | 9 | |
| 8 | 2018 | 4 | |
| 9 | 2011 | 3 |
About Dora Nomikos
Dora Nomikos is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, General Health Professions and Public Health, Environmental and Occupational Health, having authored 9 papers that have together received 190 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Genomics and Diagnostics (2 papers), Lung Cancer Treatments and Mutations (2 papers), Cancer Treatment and Pharmacology (2 papers), Advanced Breast Cancer Therapies (2 papers) and Breast Cancer Treatment Studies (1 paper). The work is most often cited by research in Oncology (102 citations), Cancer Research (33 citations), Statistics and Probability (19 citations), Radiology, Nuclear Medicine and Imaging (47 citations) and Pulmonary and Respiratory Medicine (37 citations). Dora Nomikos has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Dongsheng Tu, Stefan Baral, John R. Goffin, Lesley Seymour, Karen A. Gelmon, Wendy R. Parulekar, Yasir M. Nagarwala, Kathleen I. Pritchard, Angelo Di Leo and Alexey Manikhas. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Breast Cancer Research and Treatment and Current Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.